Balderton Capital is a leading European venture capital firm exclusively focused on backing technology companies founded in Europe. With a long history of investing and supporting European founders, they provide substantial capital and hands-on support from seed stage to IPO.

Hatteras Venture Partners is a venture capital firm with over two decades of experience investing in early-stage healthcare companies. Their focus is on building transformational human medicine companies and disrupting the status quo in healthcare through transformative therapies and disruptive technologies.

HV Capital is a leading all-stage investor in the German market and one of the leading investors in Europe. Founded in 2000, the firm supports exceptional founders in building market-leading digital companies from seed stage to exit, with over €2.8bn under management.

Activate Venture Partners is a leader in digital health and applied technology investment. Their approach is rooted in deep business, technology, and clinical expertise, and a commitment to building lasting, impactful companies.

3TS Capital Partners is a leading European technology-focused private equity and venture capital firm. They provide expansion capital and buyout funding for small and medium-sized businesses in growth sectors. 3TS experts become active business partners for portfolio companies, delivering substantial value beyond financing.

Grayhawk Capital is a venture capital firm investing primarily in B2B disruptive SaaS solutions. They focus on early-growth stage companies with strong management teams and a large addressable market. Their investments span various sectors including healthcare IT, cybersecurity, and fintech.

Acton Capital is a growth equity firm with over 25 years of experience. They invest in Series A and beyond, focusing on mission-driven teams across Europe and Canada. Their investment approach prioritizes long-term value creation over short-term hype.

Versant Ventures is a global healthcare venture capital firm. They harness the power of science to deliver strong results, managing over $4.2B and boasting 50 IPOs and 46 M&As. Their focus is on biotechnology and pharmaceuticals.

Kizoo is a technology investor focused on breakthrough technologies with global impact. They have a strong background in internet and SaaS, but currently concentrate on rejuvenation biotech and have invested in numerous companies in these fields.

Wellington Partners is a leading European venture capital firm investing in early- and growth-stage life science companies. They support entrepreneurs with breakthrough technologies and provide financial resources, expertise, and a global network to help build successful businesses. Their focus is on companies with strong management teams, innovative products, and strong IP protection.

Kaiser Permanente Ventures is a national leader in strategic venture investing in healthcare. They aim to meaningfully advance healthcare innovation by focusing on solutions that provide clear value for patients, providers, and the larger community.

Maveron is a consumer-only venture capital firm focused on partnering with world-class entrepreneurs building transformative consumer businesses. They specialize in early-stage investments and have a strong commitment to building a more inclusive and sustainable economy.